Literature DB >> 34450232

Signal transducer and activator of transcription 3 signaling in tumor immune evasion.

Luying Zhang1, Kamil Kuca2, Li You1, Yingying Zhao1, Kamil Musilek2, Eugenie Nepovimova2, Qinghua Wu3, Wenda Wu4, Vojtech Adam5.   

Abstract

The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hypoxia; Immune evasion; STAT3; Tumor microenvironment; lncRNA

Mesh:

Substances:

Year:  2021        PMID: 34450232     DOI: 10.1016/j.pharmthera.2021.107969

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  9 in total

1.  Excretory/secretory proteins inhibit host immune responses by downregulating the TLR4/NF-κB/MAPKs signaling pathway: A possible mechanism of immune evasion in parasitic nematode Haemonchus contortus.

Authors:  Zhaohai Wen; Yue Zhang; Jiajun Feng; Kalibixiati Aimulajiang; Muhammad Tahir Aleem; Mingmin Lu; Lixin Xu; Xiaokai Song; Xiangrui Li; Ruofeng Yan
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

2.  lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.

Authors:  Xiaoxia Zhang; Banglun Pan; Jiacheng Qiu; Xiaoling Ke; Shuling Shen; Xiaoqian Wang; Nanhong Tang
Journal:  Int J Exp Pathol       Date:  2022-04-15       Impact factor: 2.793

3.  Characterization of the Immune Cell Infiltration Landscape Uncovers Prognostic and Immunogenic Characteristics in Lung Adenocarcinoma.

Authors:  Xin Wang; Zhenyi Xu; Zhilin Liu; Weihao Lin; Zheng Cao; Xiaoli Feng; Yibo Gao; Jie He
Journal:  Front Genet       Date:  2022-05-23       Impact factor: 4.772

4.  Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis.

Authors:  Alberto Carretero-González; Marta Hergueta-Redondo; Sara Sánchez-Redondo; Pilar Ximénez-Embún; Luis Manso Sánchez; Eva Ciruelos Gil; Daniel Castellano; Guillermo de Velasco; Héctor Peinado
Journal:  Oncoimmunology       Date:  2022-04-23       Impact factor: 7.723

5.  UHMK1 aids colorectal cancer cell proliferation and chemoresistance through augmenting IL-6/STAT3 signaling.

Authors:  Xuedi Gao; Wenfang Bao; Jin Bai; Kailing Fan; Li Li; Yandong Li
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 9.685

Review 6.  Stat3 Signaling Pathway: A Future Therapeutic Target for Bone-Related Diseases.

Authors:  Jiadong Li; Zhifeng Yin; Biaotong Huang; Ke Xu; Jiacan Su
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

Review 7.  The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.

Authors:  Agnieszka Witalisz-Siepracka; Klara Klein; Bernhard Zdársky; Dagmar Stoiber
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

8.  N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2B.

Authors:  Hexu Han; Wei Zhu; Ting Lin; Cuixia Liu; Hengyong Zhai
Journal:  Cancer Sci       Date:  2022-08-01       Impact factor: 6.518

Review 9.  Advances and Potentials of Polydopamine Nanosystem in Photothermal-Based Antibacterial Infection Therapies.

Authors:  Shuhao Fan; Wensen Lin; Yifan Huang; Jiaojiao Xia; Jun-Fa Xu; Junai Zhang; Jiang Pi
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.